SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-16-009233
Filing Date
2016-04-18
Accepted
2016-04-18 17:00:13
Documents
12
Period of Report
2016-06-02
Effectiveness Date
2016-04-18

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_041816.htm DEF 14A 760613
2 GRAPHIC logo.jpg GRAPHIC 29129
3 GRAPHIC greenleaf.jpg GRAPHIC 24625
4 GRAPHIC alder.jpg GRAPHIC 26895
5 GRAPHIC p37.jpg GRAPHIC 187354
6 GRAPHIC p39a.jpg GRAPHIC 55895
7 GRAPHIC p39b.jpg GRAPHIC 56172
8 GRAPHIC p40a.jpg GRAPHIC 40179
9 GRAPHIC p40b.jpg GRAPHIC 43930
10 GRAPHIC p40c.jpg GRAPHIC 48165
11 GRAPHIC proxycard_1.jpg GRAPHIC 247060
12 GRAPHIC proxycard_2.jpg GRAPHIC 214886
  Complete submission text file 0001171843-16-009233.txt   2101727
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33609 | Film No.: 161577355
SIC: 2834 Pharmaceutical Preparations